|
Market Closed -
Other stock markets
|
After hours 15:06:55 | |||
| 337.00 EUR | +1.51% |
|
338.50 | +0.45% |
| 07-21 | Virbac: Impressive execution in Q2; we smell a guidance upgrade in Q3 | ![]() |
| 07-21 | Despite the escalation in the Middle East, European stocks stay the course |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 16.29x | 2.18x | 1.23x | 1.88x | 9.23x | 11.45x | 0.52% | 3.17B | ||
| 254.18x | 1.92x | -2.1x | 3.05x | 15.39x | 17.83x | -.--% | 12.44B | ||
| 7.34x | 1.07x | 0.05x | 1.05x | 3.88x | 5.08x | 3.58% | 3.63B | ||
| 33.32x | 2.15x | 0.63x | 3.82x | 13.63x | 19.72x | -.--% | 1.84B | ||
| 47.33x | 2.22x | 0.29x | - | - | - | 0.76% | 1.81B | ||
| 13.75x | 3.65x | 0.13x | 1.29x | 7.65x | 9.07x | 1.4% | 1.38B | ||
| 15.91x | 1.45x | 1.48x | 2.01x | 9.27x | 14.34x | 1.93% | 1.04B | ||
| 15.1x | 1.26x | -3.64x | 1.07x | 5.09x | 7.21x | 1.29% | 946M | ||
| 31.35x | 1.09x | 1.63x | - | - | - | 0.48% | 946M | ||
| 12.2x | 1.3x | 1x | - | - | - | - | 844M | ||
| 17.81x | 1.92x | -1.42x | - | - | - | 1.14% | 600M | ||
| 19.9x | 1.32x | -2.69x | - | - | - | - | 502M | ||
| 23.48x | 0.5x | 0.14x | 1.72x | 8.27x | 17.08x | 1.93% | 363M | ||
| 65.39x | 2.03x | -2.17x | 2.56x | 14.24x | 18.66x | 1.65% | 307M | ||
| Average | 40.95x | 1.72x | -0.39x | 2.05x | 9.63x | 13.38x | 1.22% | 2.13B | |
| Weighted average by Cap. | 118.29x | 1.85x | -0.76x | 2.43x | 11.64x | 14.30x | 0.83% |
- Stock Market
- Stocks
- VIRP Stock
- Sector Virbac
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions

















